综合传统医学与传统疗法对抗结核病:一个全面的回顾
Akriti Gaurav1, Zeeshan Fatima1, Ahmed Yaqinuddin2
1Amity Institute of Biotechnology, Amity University Haryana, Manesar, Gurugram-122413, India.
Current molecular medicine
|August 24, 2025
概括
印度传统医学,包括阿尤尔韦达,锡达和乌纳尼,在治疗结核病 (TB) 方面展现出前途. 这些天然疗法可以减少肝脏损伤和抗药性, 为传统结核病药物提供更安全的替代品.
科学领域:
- 综合医学
- 药理学
- 公共卫生
背景情况:
- 结核病 (TB) 仍然是一个全球性的健康挑战,因药物耐药性和药物诱导的肝毒性而加剧.
- 传统的抗结核治疗往往需要更长的时间表和更高的剂量,增加毒性风险.
- 印度国家结核病控制计划正在应对这些挑战.
研究的目的:
- 将传统印度医疗系统与传统结核病治疗的有效性进行比较.
- 探索艾滋病系统中的草药提取物对结核病管理的潜力.
- 评估这些替代疗法的安全性和成本效益.
主要方法:
- 对结核病的传统印度医学 (阿尤尔韦达,锡达,乌纳尼) 的科学文献的审查.
- 治疗结果的比较,包括肝毒性和耐药性.
- 分析结核病草药的安全性,成本和可获得性.
主要成果:
- 来自阿尤尔韦达,西达和乌纳尼的草药提取物显示出潜在的抗结核活性.
- 这些传统疗法可以减轻结核病药物引起的肝毒性和肝损伤.
- 在抗生素耐药性方面,
- 基于阿什的治疗通常是安全的,低成本的,没有毒素.
结论:
- 印度传统医疗系统为结核病治疗提供了可行的替代方案.
- 草药可以减少TB的不良影响并克服抗药性.
- 科学验证支持艾滋病认可的医疗系统的抗结核潜力.
相关概念视频
Pulmonary Tuberculosis V
238
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
238
Pulmonary Tuberculosis I
324
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
324
Pulmonary Tuberculosis IV
204
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
204
Pulmonary Tuberculosis II
345
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
345
Pulmonary Tuberculosis III
442
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
442
Combined Effects of Drugs: Synergism
4.7K
Synergism is a useful mechanism where combining two or more drugs is more effective than each constituent used alone. Such combinations are also called supra-additive interactions. The drugs collectively enhance the final therapeutic effect by acting on different targets. Another advantage is that the low dose of each constituent drug is sufficient to achieve the desired effect. This helps reduce the duration of therapy and lower the adverse effects of these drugs.
Such synergistic combinations...
Such synergistic combinations...
4.7K


